top of page

Specialty Infusion

Patagonia partners with provider organizations to assess potential, design, operationalize, scale and optimize specialty infusion services

Background

For decades, infusion services have been primarily driven by oncology, where complex intravenous therapies have formed the foundation of cancer treatment delivery.

 

In recent years, however, the specialty infusion therapeutics landscape has evolved significantly. Advances in biomedical research and diagnostic science have enabled the identification of hundreds of new rare diseases each year, nearly doubling the number of known rare diseases over the past five years.

 

This rapid expansion in disease recognition has, in turn, fueled therapeutic innovation. An exponentially growing number of specialty therapeutics now populate the development pipeline, with many therapies already in late-stage development or FDA-approved, addressing newly identified conditions while expanding treatment options for established diseases. Collectively, these advances have transformed our ability to diagnose, manage, and control complex conditions, altering disease trajectories and levels of control in ways previously unattainable.

 

As therapeutic options continue to expand, specialty infusion infrastructure becomes increasingly vital to effective care delivery. Yet specialty infusion services face multiple layers of internal and external complexity. Significant barriers to entry, escalating clinical and operational demands, and evolving care requirements make intentional infusion design imperative, not only to support high-quality care delivery, but also to drive operational efficiency and ensure the viability and sustainability of specialty infusion services. 

 

Patagonia Healthcare partners with provider organizations to leverage this therapeutic innovation to help meet the increasing patient care demand through validated, scalable specialty infusion strategies. Our integrated approach spans the full lifecycle of program development, from assessing addressable opportunity and developing center-specific pro formas, to program design, implementation, real-time operational support, clinical service development, and proven scalability strategies.  Patagonia Healthcare is your partner in creating, scaling, and optimizing specialty infusion services, diversifying your service and revenue mix, while positioning you as the patient destination of choice for access to the most innovative specialty therapeutics.

Outcomes

Infusion Access to Hospital Managed Care Contracts 

Access to 340B Pricing 

Build Within Existing Real-Estate Infrastructure 

Sites Achieving Break Even Within Six Months of Launch 

Compliance With Drug Protocol Development 

100%

Centralization of Intake, Authorization, Scheduling and Patient Financial Services 

<1%

Drug Referral Bounce Back 

Fatal Drug Denial Rate 

>90% Drug Authorization Success in HOPD Setting 

70% Net New Revenue 

60% Net New Patients 

Open Drug Formulary Strategy 

Validated HOPD Models Operating for 5 Years 

Hospital Length of Stay Optimization 

Reduction of Hospital Acute Drug Budget 

Diversification of Service Mix 

Diversification of Revenue Streams 

Largest Market Share Capture of Rare Disease Specialty Infusions 

Services

Request a Strategy Consult

Upcoming Availability
January 2026
SunMonTueWedThuFriSat
Week starting Sunday, January 25
Time zone: Coordinated Universal Time (UTC)Online meeting
Wednesday, Jan 28
10:00 AM - 11:00 AM
11:00 AM - 12:00 PM
12:00 PM - 1:00 PM
1:00 PM - 2:00 PM

Your Partner
 

For All Things
 

Specialty  Infusion 

image.png
bottom of page